HESTERBIO

Hester Biosciences Share PriceHester Biosciences

₹1523.65
-12.6 (-0.82%)
As on 29 November, 2023 | 02:22 BSE: 524669 NSE: HESTERBIOISIN: INE782E01017

Hester Biosciences Performance

Day Range

  • Low 1518.1
  • High 1540
1523.65

52 Week Range

  • Low 1404.55
  • High 2015
1523.65
  • Open Price1540
  • Previous Close1540
  • Volume3310

Start SIP in Hester Biosciences

Start SIP

Hester Biosciences Share Price

  • Over 1 Month -7.63%
  • Over 3 Month -10.45%
  • Over 6 Month -8.04%
  • Over 1 Year -20.97%

Hester Biosciences Key Statistics

P/E Ratio 50.5
PEG Ratio -9.5
Market Cap Cr 1,296
Price to Book Ratio 4.5
EPS 38
Dividend 0.5
Relative Strength Index 32.04
Money Flow Index 25.55
MACD Signal -32.12
Average True Range 37.08

Hester Biosciences Investment Rating

  • Master Rating:
  • Hester Biosciences has an operating revenue of Rs. 300.55 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 13% is healthy, ROE of 9% is fair but needs improvement. The company has a debt to equity of 66%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 8 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 117 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Hester Biosciences Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 66806171725150
Operating Expenses Qtr Cr 54695052564140
Operating Profit Qtr Cr 1211111916910
Depreciation Qtr Cr 3332223
Interest Qtr Cr 1103211
Tax Qtr Cr 2234422
Net Profit Qtr Cr 766111055
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 259224
Operating Expenses Annual Cr 199159
Operating Profit Annual in Cr 5561
Depreciation Cr 1010
Interest Annual Cr 62
Tax Annual Cr 1214
Net Profit Annual Cr 3240
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3316
Cash from Investing Activity Annual Cr -72-111
Cash from Financing Annual Activity Cr 4195
Net Cash Flow Annual Cr 30
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 292268
Fixed Assets Annual Cr 257166
Total Non Current Assets Annual Cr 330258
Total Current Assets Annual Cr 216166
Total Assets Annual Cr 546424
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 344316
ROE Annual % 1115
ROCE Annual % 1216
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2430
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 70886775735156
Operating Expenses Qtr Cr 57735656604346
Operating Profit Qtr Cr 1314121913710
Depreciation Qtr Cr 4555555
Interest Qtr Cr 8314222
Tax Qtr Cr 3234422
Net Profit Qtr Cr 46511748
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 281249
Operating Expenses Annual Cr 215175
Operating Profit Annual in Cr 5160
Depreciation Cr 2117
Interest Annual Cr 94
Tax Annual Cr 1214
Net Profit Annual Cr 2739
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 249
Cash from Investing Activity Annual Cr -77-117
Cash from Financing Annual Activity Cr 42112
Net Cash Flow Annual Cr -124
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 280260
Fixed Assets Annual Cr 408319
Total Non Current Assets Annual Cr 442367
Total Current Assets Annual Cr 228195
Total Assets Annual Cr 670562
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 339314
ROE Annual % 1015
ROCE Annual % 912
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2531

Hester Biosciences Technicals

EMA & SMA

Current Price
₹1523.65
-12.6 (-0.82%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹1578.15
  • 50 Day
  • ₹1627.13
  • 100 Day
  • ₹1664.11
  • 200 Day
  • ₹1728.6
  • 20 Day
  • ₹1590.35
  • 50 Day
  • ₹1640.62
  • 100 Day
  • ₹1682.44
  • 200 Day
  • ₹1702.38

Hester Biosciences Resistance and Support

PIVOT
₹1527.25
Resistance
First Resistance ₹1536.4
Second Resistance ₹1549.15
Third Resistance ₹1558.3
RSI 32.04
MFI 25.55
MACD Single Line -32.11
MACD -35.97
Support
First Resistance ₹1514.5
Second Resistance ₹1505.35
Third Resistance ₹1492.6

Hester Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,387 264,897 78.21
Week 2,877 201,983 70.2
1 Month 4,421 300,022 67.86
6 Month 6,036 389,431 64.52

Hester Biosciences Result Highlights

Hester Biosciences Synopsis

NSE-Medical-Ethical Drugs

Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 254.00 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2023. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
Market Cap 1,296
Sales 278
Shares in Float 0.39
No of funds 15
Yield 0.53
Book Value 4.43
U/D Vol ratio 0.5
LTDebt / Equity 29
Alpha -0.11
Beta 0.64

Hester Biosciences

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 53.73%53.73%53.73%53.73%
Mutual Funds 0.03%
Foreign Portfolio Investors 0.42%0.45%0.45%0.45%
Individual Investors 33.19%33.36%33.02%32.96%
Others 12.66%12.46%12.8%12.83%

Hester Biosciences Management

Name Designation
Dr. Bhupendra Gandhi Chairman
Mr. Rajiv Gandhi Managing Director & CEO
Ms. Priya Gandhi Executive Director
Mr. Ravin Gandhi Director
Mr. Sanjiv Gandhi Director
Mr. Ashok Bhadakal Independent Director
Ms. Sandhya Patel Independent Director
Mr. Ameet Desai Independent Director
Ms. Nina Gandhi Alternate Director

Hester Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hester Biosciences Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-08 Quarterly Results
2023-05-17 Audited Results & Final Dividend
2023-01-31 Quarterly Results
2022-11-04 Quarterly Results

Hester Biosciences MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8

Hester Biosciences FAQs

What is Share Price of Hester Biosciences ?

Hester Biosciences share price is ₹1523 As on 29 November, 2023 | 02:08

What is the Market Cap of Hester Biosciences ?

The Market Cap of Hester Biosciences is ₹1296.2 Cr As on 29 November, 2023 | 02:08

What is the P/E ratio of Hester Biosciences ?

The P/E ratio of Hester Biosciences is 50.5 As on 29 November, 2023 | 02:08

What is the PB ratio of Hester Biosciences ?

The PB ratio of Hester Biosciences is 4.5 As on 29 November, 2023 | 02:08

Q2FY23